The Parker Institute for Cancer Immunotherapy
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:research_institute
|
| gptkbp:collaboratesWith |
leading cancer centers
|
| gptkbp:focus |
immunotherapy
|
| gptkbp:foundedBy |
gptkb:Sean_Parker
|
| gptkbp:foundedIn |
2016
|
| gptkbp:headquartersLocation |
gptkb:San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
The Parker Institute for Cancer Immunotherapy
|
| gptkbp:mission |
accelerate the development of breakthrough immune therapies to turn cancer into a curable disease
|
| gptkbp:namedAfter |
gptkb:Sean_Parker
|
| gptkbp:notableContributor |
gene therapy
tumor microenvironment checkpoint inhibitors |
| gptkbp:partner |
pharmaceutical companies
biotechnology companies academic research institutions |
| gptkbp:researchArea |
immuno-oncology
|
| gptkbp:type |
gptkb:nonprofit_organization
|
| gptkbp:website |
https://www.parkerici.org/
|
| gptkbp:bfsParent |
gptkb:Michael_Polansky
|
| gptkbp:bfsLayer |
5
|